To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250 mg/5 ml Oral Suspension Fed Conditions

NCT00883883 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Cefdinir 250 mg/5 ml Suspension (Sandoz, Austria)
DRUG: Omnicef Cefdinir 250 mg/5 ml Suspension (Abbott Laboratories, USA)

Sponsor

Sandoz